Diabetes Board decisions

The Board has decided to remand the case due to a need for further examination and development of records, particularly regarding the Veteran's diabetes mellitus with erectile dysfunction.

The Board has remanded the claims of service connection for diabetes mellitus Type II and bilateral peripheral neuropathy of the lower extremities due to exposure to herbicide agents, as there is insufficient competent medical evidence to make a decision on these claims. The Veteran's contentions of exposure to herbicide agents have not been conceded by VA.

The Board denied service connection for diabetes mellitus type 2 and a left leg condition with pain and swelling, finding no current diagnosis of these conditions. The Veteran's claims were based on presumed exposure to herbicide agents (Agent Orange), but the evidence did not support such presumptive service connection.

The Veteran's service-connected type II diabetes mellitus resulted in diabetic peripheral neuropathy affecting both lower extremities. The Board granted separate ratings for the right and left lower extremities, with a 10 percent rating prior to October 5, 2019, and a 20 percent rating from that date onward.

The Board denied the Veteran's claim for service connection for diabetes mellitus, finding that there was no evidence of herbicide exposure and insufficient continuity of symptoms to establish a link between active duty service and current diabetes mellitus.

The Veteran's claims for service connection and increased ratings have been granted. The skin disability of the scalp claim was withdrawn, while bilateral hearing loss, bilateral tinnitus, diabetes mellitus with erectile dysfunction and bilateral cataracts, left lower extremity peripheral neuropathy, and right lower extremity peripheral neuropathy were all granted. Increased ratings of 20 percent for both lower extremity peripheral neuropathies have been awarded.

The Board dismissed all claims due to the death of the appellant, as it has no jurisdiction to adjudicate the merits of these appeals at this time.

The Board denied service connection for diabetes mellitus, PVD of the bilateral lower extremities, peripheral neuropathy of the bilateral upper and lower extremities, and erectile dysfunction. The Veteran's claims were not granted as secondary to a service-connected condition or due to presumed exposure to herbicide agents.

The Board denied the Veteran's claim for a total disability rating based on individual unemployability due to service-connected disabilities, finding that his service-connected conditions did not render him unable to secure or follow a substantially gainful occupation.

The Board denied service connection for a heart disorder and diabetes mellitus, type II as the evidence did not show that these conditions were incurred in or related to active duty.

The Board has remanded the Veteran's claims for compensation under 38 U.S.C. § 1151 due to issues with obtaining informed consent records and further medical opinions regarding aggravation of autoimmune pancreatitis.

The Board has determined that the Veteran's service connection claim for diabetes mellitus, type II as due to herbicide exposure is granted based on his credible statements of having operated in or near the DMZ during the relevant time period.

The Board has remanded the claims for diabetes mellitus and related peripheral neuropathy due to potential herbicide exposure in Okinawa, Japan. The Veteran's service records indicate possible aircraft exposures but no definitive evidence of Agent Orange exposure. Further development is needed to verify these allegations.

The Veteran's hypertension is secondary to his service-connected depressive disorder and type 2 diabetes, and the Board has granted this claim.,The Veteran's headaches are also secondary to his service-connected depressive disorder and hypertension. The Board has granted this claim as well.

The Veteran's diabetes mellitus with erectile dysfunction is currently rated at 10 percent, and the issues of increased ratings for diffuse sensorimotor neuropathy in both upper extremities prior to September 24, 2019 are being remanded.,For the right and left upper extremity diffuse sensorimotor neuropathy prior to September 24, 2019, the Veteran is rated at 20 percent. The issues of increased ratings for diffuse sensorimotor neuropathy in both lower extremities prior to June 22, 2017 are being remanded.

The Board has determined that the Veteran's claims for service connection and increased ratings are remanded due to the need for additional medical opinions regarding his low back disability, bilateral hip disabilities, carpal tunnel syndrome, and asthma. The claims will be returned to the RO for further development.

The Board has granted service connection for diabetes mellitus type II, finding that the Veteran's exposure to herbicide agents in Vietnam is presumed and his current diagnosis of Type II diabetes is also established.

The Board dismissed all appeals regarding service connection for diabetes mellitus type II, peripheral neuropathy of the right lower extremity, and peripheral neuropathy of the left lower extremity due to withdrawal by the appellant.

The Veteran's claims for service connection for diabetes mellitus and Gulf War syndrome were denied, and his claim for an effective date prior to September 29, 2010 for PTSD and schizotypal personality disorder was dismissed. The Board found that the evidence did not meet the threshold for reopening the previously denied claims.

The Veteran's claims for increased rating, service connection for diabetes mellitus, type II, xerostomia (dry mouth), and missing teeth and dental caries are remanded due to the need for additional development of the record.